Weak Statistical Standards Implicated in Scientific Irreproducibility
By Erika Check Hayden,
Nature
| 11. 11. 2013
The
plague of non-reproducibility in science may be mostly due to scientists’ use of weak statistical tests, as shown by an innovative method developed by statistician Valen Johnson, at Texas A&M University in College Station.
Johnson compared the strength of two types of tests: frequentist tests, which measure how unlikely a finding is to occur by chance, and Bayesian tests, which measure the likelihood that a particular hypothesis is correct given data collected in the study. The strength of the results given by these two types of tests had not been compared before, because they ask slightly different types of questions.
So Johnson developed a method that makes the results given by the tests — the P value in the frequentist paradigm, and the Bayes factor in the Bayesian paradigm — directly comparable. Unlike frequentist tests, which use objective calculations to reject a null hypothesis, Bayesian tests require the tester to define an alternative hypothesis to be tested — a subjective process. But Johnson developed a 'uniformly most powerful' Bayesian test that defines the alternative hypothesis in a standard way...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...